Next report date
Report period
Q1 2024
EPS estimate
—
Revenue estimate
—
−41.44 MSEK
1.36 MSEK
About PROSTATYPE GENOMICS AB
Sector
CEO
Fredrik Persson
Headquarters
Solna
Website
Employees (FY)
5
Founded
2007
FIGI
BBG00XGCF916
Prostatype Genomics AB manufactures, markets and sells the prognostic gene test Prostatype. It helps clinicians and patients to make correct treatment decisions. The company was founded in 2007 and is headquartered in Solna, Sweden.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of PROGEN is 0.0364 SEK — it has decreased by 3.70% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OMXSTO exchange PROSTATYPE GENOMICS AB stocks are traded under the ticker PROGEN.
PROSTATYPE GENOMICS AB is going to release the next earnings report on May 23, 2024. Keep track of upcoming events with our Earnings Calendar.
PROGEN stock is 13.10% volatile and has beta coefficient of 2.23. Check out the list of the most volatile stocks — is PROSTATYPE GENOMICS AB there?
Yes, you can track PROSTATYPE GENOMICS AB financials in yearly and quarterly reports right on TradingView.
PROGEN stock has fallen by 14.95% compared to the previous week, the month change is a 38.93% fall, over the last year PROSTATYPE GENOMICS AB has showed a 94.89% decrease.
Today PROSTATYPE GENOMICS AB has the market capitalization of 27.09 M, it has decreased by 6.96% over the last week.
No, PROGEN doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PROGEN shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PROSTATYPE GENOMICS AB stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 27, 2024, the company has 5.00 employees. See our rating of the largest employees — is PROSTATYPE GENOMICS AB on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PROSTATYPE GENOMICS AB technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PROSTATYPE GENOMICS AB stock shows the sell signal. See more of PROSTATYPE GENOMICS AB technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.